ZX1010 Platform
The ZX1010 platform can be configured with a maximum of 4 AirJet HR, 4 BioJet HR, 4 FrontLine HR, or 4 PolyDrop dispensers. Dispensers are sold separately so each machine can be customized to meet the application needs.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The ZX1010 platform can be configured with a maximum of 4 AirJet HR, 4 BioJet HR, 4 FrontLine HR, or 4 PolyDrop dispensers. Dispensers are sold separately so each machine can be customized to meet the application needs.
Brochures
Tools and technologies for lateral flow assay development and manufacturing
This brochure presents BioDot’s range of technologies designed to support the development and large‑scale manufacturing of lateral flow assays. Covering the full workflow from reagent deposition and drying to lamination, cutting and automated assembly, the solutions enable precise, reproducible production of rapid diagnostic tests. The portfolio includes multiple dispensing technologies and modular systems that support both research and high‑throughput manufacturing environments. By ensuring consistent reagent placement and scalable workflows, these tools help accelerate the transition from assay development to commercial production for point‑of‑care diagnostics.
Introducing the essentials for lateral flow test production
BioDot offers manufactured, non-contact and quantitative fluid dispensing systems for the industrial, life science, diagnostic, and medical product markets. Explore the wide range of equipment that can be used in the production of lateral flow tests, and discover how BioDot provides the flexibility to tailor your dispensing technology, platform and the quantity of dispensers for ease of use.
Keeping things flowing from end to end with Biodot
DCN Dx offers end-to-end services – from assay development and validation to manufacturing and clinical research services – and relies on BioDot equipment for its deposition needs. Dr Pat Vaughan, Chief Operating Officer at DCN Dx, explains how the company has elevated its lateral flow test manufacturing with support from Biodot, and how DCN Dx has continued to grow as a contract research development and manufacturing (CRDMO) service for in vitro diagnostics.
